Katrina Settlement a Wake-Up Call on Emergency Preparedness

Tenet will pay $25 million to patients and visitors who died or were injured at one of its former New Orleans hospitals after Hurricane Katrina. Their class-action lawsuit accused Tenet of inadequate emergency preparedness. Medscape Medical News

HHS Proposes New Rules for Human Research

WASHINGTON (MedPage Today) — The Department of Health and Human Services has announced it is planning to change its rules on research involving human study participants.

Washington Week: Debt Ceiling Standoff Endures

WASHINGTON (MedPage Today) — President Barack Obama and Congress appeared close to reaching a deficit reducing, debt-ceiling deal — in part by making major healthcare cuts — but the deal collapsed as the week ended.

Taiho Pharmaceutical Announces Results Of Randomized Phase II Clinical Trial With Novel Antitumor Agent TAS-102

Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Toru Usami) announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at the 9th Annual Meeting of the Japanese Society of Medical Oncology held in Yokohama. (Abstract [...]

Isis Initiates Phase 1 Study Of ISIS-PTP1BRx To Treat Type 2 Diabetes

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B. ISIS-PTP1BRx is designed to increase the body’s sensitivity to the natural hormone insulin, resulting in better glucose control for patients with type [...]

Boca Pharmacal Receives FDA Approval On Hydrocodone Bitartrate And Acetaminophen Oral Solution

Boca Pharmacal, Inc., announced that it has received approval from the FDA of its Abbreviated New Drug Application (ANDA) for Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5mL, the generic version of Hycet® Oral Solution distributed by FSC Laboratories, Inc…

Pharmasset Announces Final SVR Data From PROTON Trial With PSI-7977 In Subjects Infected With Hepatitis C Infection Genotype 2 Or 3

Pharmasset, Inc. (Nasdaq: VRUS) announced the final sustained virologic response (SVR) results from its phase 2b PROTON study with PSI-7977 dosed once daily in combination with peginterferon alfa 2a and ribavirin (Peg-IFN/RBV) in subjects with hepatitis C virus (HCV) genotype 2 or 3 who have not been treated previously…

Working Mothers And The Effects On Children

Parents struggling to combine paid work with bringing up their children now have some positive news thanks to a new study funded by the Economic and Social Research Council (ESRC) on maternal employment and child socio-emotional behaviour in the UK…

Male Infertility Tied To Common Gene Mutation That Lets Sperm Get Zapped By Female Immune System

A common gene mutation that causes sperm to lose its protective protein coat so it falls prey to the female immune system on its journey to the egg, may be the main reason for infertility in men worldwide, writes an international team of researchers in a paper published in the journal Science Translational [...]

Parental Military Deployment Has Detrimental Affect On Adolescent Boys

In 2007, nearly two million children in the United States had at least one parent serving in the military. Military families and children, in particular, suffer from mental health problems related to long deployments…